ACS Diagnostics
Private Company
Funding information not available
Overview
ACS Diagnostics, founded in 2005 and headquartered in Carlsbad, California, is a private commercial-stage company focused on the diagnostics sector, specifically cardiac monitoring. Its core business combines the manufacturing of proprietary, reusable Holter and mobile cardiac telemetry (MCT) devices with the operation of a certified diagnostic laboratory that provides full-disclosure analysis. The company positions itself as a technology and service leader through its emphasis on high-resolution, full-disclosure ECG data, telemedicine integration, and environmentally conscious reusable devices. A recent strategic partnership and new telemedicine patents indicate an active growth and innovation strategy.
Technology Platform
Proprietary wearable ambulatory ECG monitors (Clip Holter, CORE3) enabling Holter, Event, and Mobile Cardiac Telemetry (MCT) monitoring, integrated with a telemedicine platform and a certified IDTF laboratory for full-disclosure, high-resolution ECG analysis.
Opportunities
Risk Factors
Competitive Landscape
ACS Diagnostics competes in the crowded cardiac monitoring market against large, diversified players like Philips (BioTelemetry) and iRhythm Technologies, as well as other IDTFs and device manufacturers. Its key differentiators are its vertical integration (device + lab), emphasis on full-disclosure analysis by certified technicians, and its reusable hardware. However, it faces pressure from consumer-grade wearables (e.g., Apple Watch) that are gaining clinical acceptance for arrhythmia screening.